Panagora Asset Management’s Inovio Pharmaceuticals INO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-4,752
| Closed | -$117K | – | 2513 |
|
|
2019
Q3 | $117K | Sell |
4,752
-8,639
| -65% | -$213K | ﹤0.01% | 1784 |
|
|
2019
Q2 | $472K | Sell |
13,391
-74,978
| -85% | -$2.64M | ﹤0.01% | 1448 |
|
|
2019
Q1 | $3.96M | Buy |
88,369
+28,581
| +48% | +$1.28M | 0.02% | 583 |
|
|
2018
Q4 | $2.87M | Buy |
59,788
+5,900
| +11% | +$283K | 0.01% | 637 |
|
|
2018
Q3 | $3.6M | Buy |
53,888
+26,371
| +96% | +$1.76M | 0.01% | 619 |
|
|
2018
Q2 | $1.29M | Sell |
27,517
-39,429
| -59% | -$1.85M | 0.01% | 1056 |
|
|
2018
Q1 | $3.78M | Buy |
66,946
+11,179
| +20% | +$632K | 0.01% | 633 |
|
|
2017
Q4 | $2.76M | Sell |
55,767
-2,765
| -5% | -$137K | 0.01% | 746 |
|
|
2017
Q3 | $4.45M | Sell |
58,532
-4,387
| -7% | -$334K | 0.02% | 606 |
|
|
2017
Q2 | $5.92M | Sell |
62,919
-2,854
| -4% | -$268K | 0.02% | 527 |
|
|
2017
Q1 | $5.23M | Buy |
65,773
+32,532
| +98% | +$2.58M | 0.02% | 577 |
|
|
2016
Q4 | $2.77M | Hold |
33,241
| – | – | 0.01% | 762 |
|
|
2016
Q3 | $3.72M | Buy |
33,241
+2,815
| +9% | +$315K | 0.02% | 654 |
|
|
2016
Q2 | $3.37M | Sell |
30,426
-143
| -0.5% | -$15.9K | 0.02% | 687 |
|
|
2016
Q1 | $3.2M | Buy |
30,569
+1,940
| +7% | +$203K | 0.02% | 710 |
|
|
2015
Q4 | $2.31M | Buy |
28,629
+16,182
| +130% | +$1.31M | 0.01% | 772 |
|
|
2015
Q3 | $863K | Buy |
12,447
+977
| +9% | +$67.7K | ﹤0.01% | 1095 |
|
|
2015
Q2 | $1.12M | Buy |
+11,470
| New | +$1.12M | 0.01% | 1040 |
|